Drug Shortage Report for FUROSEMIDE INJECTION USP

Last updated on 2018-03-03 History
Report ID 26269
Drug Identification Number 02461404
Brand name FUROSEMIDE INJECTION USP
Common or Proper name FUROSEMIDE INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) FUROSEMIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 25 VIALS
ATC code C03CA
ATC description HIGH-CEILING DIURETICS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2017-10-18
Estimated end date 2018-03-05
Actual end date 2018-03-02
Shortage status Resolved
Updated date 2018-03-03
Company comments Product is available at wholesalers.
Health Canada comments
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2018-03-03 English Compare
v18 2018-03-02 French Compare
v17 2018-03-02 English Compare
v16 2018-03-02 English Compare
v15 2018-03-02 French Compare
v14 2018-03-02 English Compare
v13 2018-02-22 French Compare
v12 2018-02-22 English Compare
v11 2018-02-05 French Compare
v10 2018-02-05 English Compare
v9 2018-01-08 French Compare
v8 2018-01-08 English Compare
v7 2017-11-23 French Compare
v6 2017-11-23 English Compare
v5 2017-11-02 French Compare
v4 2017-11-02 English Compare
v3 2017-10-19 English Compare
v2 2017-10-18 French Compare
v1 2017-10-18 English Compare